Ertapenem | an antibiotic of the beta-lactam group

Ertapenem | an antibiotic of the beta-lactam group

Share this

Ertapenem is an antibiotic of the beta-lactam group. It has the ability to kill a wide range of bacteria (germs) that cause infections in various parts of the body. Antibiotic Class: Carbapenem

Antimicrobial Spectrum:

Aerobic gram-positive microorganisms: S. aureus (methicillin susceptible strains only), S.pyogenes, S. agalactiae; Aerobic gram-negative microorganisms: E. coli, H. influenzae, M. catarrhalis, K. pneumonia; anaerobic microorganisms: Bacteroides fragilis and other Bacteroides species, C.clostridioforme, Peptostreptococcus species


Treatment of the following moderate-to-severe infections: Complicated intra-abdominal infections, complicated skin and skin structure infections (including diabetic foot infections without osteomyelitis, animal and human bites), complicated UTI (including pyelonephritis), acute pelvic infections (including postpartum endomyometritis, septic abortion, postsurgical gynecologic infections), and community-acquired pneumonia. Prophylaxis of surgical site infection following elective colorectal surgery. Antibacterial coverage includes aerobic grampositive organisms, aerobic gram-negative organisms, and anaerobic organisms.


Sterile lyophilized 1 g powder for intravenous infusion or for intramuscular injection Acute pelvic infection: 1 g IV/IM daily for 3-10 days Community-acquired pneumonia: 1 g IV/IM daily for 10-14 days Intra-abdominal infections: 1 g IV/IM daily for 5-14 days Skin/skin structure infections: 1 g IV/IM daily for 7-14 days Urinary tract infection: 1 g IV/IM daily for 10-14 days


Adverse Effects:
: Nausea, diarrhea, abdominal pain, vomiting, constipation, GERD

Cardiovascular System: Edema, chest pain, tachycardia

Central Nervous System: Headache, altered mental status (confusion, disorientation, somnolence), seizures

Hematologic: Decreases in hemoglobin and hematocrit, decrease in platelet counts, eosinophilia

Genitourinary: Vaginitis

Renal: Renal insufficiency

Hepatic: Increased serum transaminases and alkaline phosphatase

Respiratory: Dyspnea, cough, pharyngitis, and “respiratory distress”

Dermatologic: Erythrema, pruritis, rash; extravasation at injection site, phlebitis, thrombophlebitis


Contraindications: Prior anaphylactic reactions to beta- lactams, hypersensitivity to amide-type anesthetics

Precautions: Known or suspected CNS disorders including seizure history (increased risk for seizures)

Drug Interactions: Probenecid (moderate severity): Probenecid inhibits the renal excretion of ertapenem thereby increasing its plasma concentrations and prolonging its elimination half- life.

Pregnancy: Category B: No evidence of risk in humans but studies inadequate.

Brand names/Manufacturer: Invanz/Merck in the following countries: Australia, United Kingdom, Singapore, New Zealand, Germany, Ireland, France, Austria, Sweden, Israel, Finland, and Belgium

Share this

Leave a Reply